blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3110972

EP3110972 - PREDICTION OF PREECLAMPSIA USING MICRORNA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.04.2019
Database last updated on 30.10.2024
FormerGrant of patent is intended
Status updated on  04.07.2018
FormerExamination is in progress
Status updated on  03.11.2017
FormerRequest for examination was made
Status updated on  02.12.2016
Most recent event   Tooltip12.04.2019Application deemed to be withdrawnpublished on 15.05.2019  [2019/20]
Applicant(s)For all designated states
Friedrich Miescher Institute for Biomedical Research
Maulbeerstrasse 66
4058 Basel / CH
For all designated states
University Hospital Basel
Hebelstrasse 32
4031 Basel / CH
[2017/01]
Inventor(s)01 / BUEHLER, Marc
Bettingerstrasse 279
4125 Riehen / CH
02 / LALEVÉE, Sébastien
535 Rue de l'Espinouse
Appartement 203
34090 Montpellier / FR
03 / LAPAIRE, Olav
Neubadrain 92
4102 Binningen / CH
 [2017/01]
Representative(s)Favre, Nicolas, et al
Friedrich Miescher Institute for
Biomedical Research
Maulbeerstrasse 66
4058 Basel / CH
[2017/01]
Application number, filing date15714022.926.02.2015
[2017/01]
WO2015IB51442
Priority number, dateEP2014015729828.02.2014         Original published format: EP 14157298
[2017/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015128836
Date:03.09.2015
Language:EN
[2015/35]
Type: A1 Application with search report 
No.:EP3110972
Date:04.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 03.09.2015 takes the place of the publication of the European patent application.
[2017/01]
Search report(s)International search report - published on:EP03.09.2015
ClassificationIPC:C12Q1/68
[2017/01]
CPC:
C12Q1/6883 (EP,US); G01N33/689 (US); G01N33/6893 (EP,US);
C12Q2600/158 (EP,US); C12Q2600/178 (EP,US); G01N2800/368 (US);
G01N2800/50 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/01]
TitleGerman:VORHERSAGE VON PRÄEKLAMPSIE MITTELS MICRORNA[2017/01]
English:PREDICTION OF PREECLAMPSIA USING MICRORNA[2017/01]
French:PRÉDICTION DE LA PRÉÉCLAMPSIE À L'AIDE DE MICRO-ARN[2018/29]
Former [2017/01]PRÉDICTION DE PRÉÉCLAMPSIE À L'AIDE DE MICROARN
Entry into regional phase28.09.2016National basic fee paid 
28.09.2016Designation fee(s) paid 
28.09.2016Examination fee paid 
Examination procedure10.08.2016Date on which the examining division has become responsible
28.09.2016Examination requested  [2017/01]
10.04.2017Amendment by applicant (claims and/or description)
03.11.2017Despatch of a communication from the examining division (Time limit: M04)
22.02.2018Reply to a communication from the examining division
05.07.2018Communication of intention to grant the patent
15.11.2018Fee for grant paid
15.11.2018Fee for publishing/printing paid
16.11.2018Application deemed to be withdrawn, date of legal effect  [2019/20]
02.01.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2019/20]
Fees paidRenewal fee
10.02.2017Renewal fee patent year 03
14.02.2018Renewal fee patent year 04
28.02.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2009093254  (ROSETTA GENOMICS LTD [IL], et al) [Y] 2-10 * pg 5, l 16-20; Fig 4; cl 5, 7, 9, 18. *;
 [XYI]  - ROMAN A ET AL, "237: Microrna expression in placenta of patients with preeclampsia", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, vol. 199, no. 6, doi:10.1016/J.AJOG.2008.09.265, ISSN 0002-9378, (20081201), page S78, (20081201), XP025766764 [X] 8 * the whole document * [Y] 2-10 [I] 1

DOI:   http://dx.doi.org/10.1016/j.ajog.2008.09.265
 [Y]  - LAUREN ANTON ET AL, "miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia", AMERICAN JOURNAL OF PATHOLOGY; [10640], ELSEVIER INC, US, vol. 183, no. 5, ISSN 0002-9440, (20131101), pages 1437 - 1445, (20130910), XP009179018 [Y] 2-10 * pg 1437, 1441. *

DOI:   http://dx.doi.org/10.1016/j.ajpath.2013.07.021
 [Y]  - ZHU X M ET AL, "Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, vol. 200, no. 6, doi:10.1016/J.AJOG.2008.12.045, ISSN 0002-9378, (20090601), pages 661.e1 - 661.e7, (20090314), XP026142518 [Y] 2-10 * pg 661e4-661e5. *

DOI:   http://dx.doi.org/10.1016/j.ajog.2008.12.045
 [XY]  - O. ISHIBASHI ET AL, "Hydroxysteroid (17- ) Dehydrogenase 1 Is Dysregulated by Mir-210 and Mir-518c That Are Aberrantly Expressed in Preeclamptic Placentas: A Novel Marker for Predicting Preeclampsia", HYPERTENSION, (20111227), vol. 59, no. 2, doi:10.1161/HYPERTENSIONAHA.111.180232, ISSN 0194-911X, pages 265 - 273, XP055188493 [X] 7 * abstract, pg 268, right col, second par; table S1, table S2. * [Y] 2-6,8-10

DOI:   http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.180232
 [T]  - S LALEVÉE ET AL, "miR455 is linked to hypoxia signaling and is deregulated in preeclampsia", CELL DEATH AND DISEASE, (20140904), vol. 5, no. 9, doi:10.1038/cddis.2014.368, page e1408, XP055188495 [T] 1-10

DOI:   http://dx.doi.org/10.1038/cddis.2014.368
by applicantUS4683195
 US4683202
    - MURPHY ET AL., ENDOCR REV., (200604), vol. 27, no. 2, pages 141 - 69
    - STEEGERS ET AL., LANCET, (20100821), vol. 376, no. 9741, pages 631 - 44
    - ROBERTS ET AL., PLACENTA, (200903), vol. 30, no. A, pages 32 - 7
    - VERLOHREN, S.; H. STEPAN ET AL., "Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia", CLINICAL SCIENCE, (2012), vol. 122, no. 2, doi:doi:10.1042/cs20110097, pages 43 - 52, XP002688317

DOI:   http://dx.doi.org/10.1042/cs20110097
    - YOUNG, B. C.; R. J. LEVINE ET AL., "Pathogenesis of preeclampsia", ANNUAL REVIEW OF PATHOLOGY, (2010), vol. 5, doi:doi:10.1146/annurev-pathol-121808-102149, pages 173 - 192, XP055021569

DOI:   http://dx.doi.org/10.1146/annurev-pathol-121808-102149
    - REDMAN, C. W., "Preeclampsia: a multi-stress disorder", LA REVUE DE MEDECINE INTERNE / FONDEE ..., (2011), vol. 32, no. 1, pages 41 - 44
    - WANG, A.; S. RANA ET AL., "Preeclampsia: the role of angiogenic factors in its pathogenesis", PHYSIOLOGY, (2009), vol. 24, pages 147 - 158
    - GEORGE, E. M.; J. P. GRANGER, "Recent insights into the pathophysiology of preeclampsia", EXPERT REVIEW OF OBSTETRICS & GYNECOLOGY, (2010), vol. 5, no. 5, pages 557 - 566
    - KROL J ET AL., NAT REV GENET, (201009), vol. 11, no. 9, pages 597 - 610
    - CHIANG, H. R.; L. W. SCHOENFELD ET AL., "Mammalian microRNAs: experimental evaluation of novel and previously annotated genes", GENES & DEVELOPMENT, (2010), vol. 24, no. 10, doi:doi:10.1101/gad.1884710, pages 992 - 1009, XP055019380

DOI:   http://dx.doi.org/10.1101/gad.1884710
    - GRIFFITHS-JONES, S., "The microRNA Registry", NUCLEIC ACIDS RESEARCH, (2004), vol. 32, doi:doi:10.1093/nar/gkh023, pages D109 - 11, XP002392427

DOI:   http://dx.doi.org/10.1093/nar/gkh023
    - KROL J ET AL., NAT REV GENET., (201009), vol. 11, no. 9, pages 597 - 610
    - BARTEL DP, CELL, (20090123), vol. 136, no. 2, pages 215 - 33
    - LIANG, Y.; D. RIDZON ET AL., "Characterization of microRNA expression profiles in normal human tissues", BMC GENOMICS, (2007), vol. 8, doi:doi:10.1186/1471-2164-8-166, page 166, XP021027980

DOI:   http://dx.doi.org/10.1186/1471-2164-8-166
    - VENTURA, A.; T. JACKS, "MicroRNAs and cancer: short RNAs go a long way", CELL, (2009), vol. 136, no. 4, pages 586 - 591
    - HAMILTON, M. P.; M. O. GORE ET AL., "Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution", DIABETES & VASCULAR DISEASE RESEARCH : OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF DIABETES AND VASCULAR DISEASE, (2011), vol. 8, no. 3, pages 190 - 194
    - MORALES-PRIETO, D. M.; W. CHAIWANGYEN ET AL., "MicroRNA expression profiles of trophoblastic cells", PLACENTA, (2012), vol. 33, no. 9, doi:doi:10.1016/j.placenta.2012.05.009, pages 725 - 734, XP028935177

DOI:   http://dx.doi.org/10.1016/j.placenta.2012.05.009
    - GIRARDOT, M; J. CAVAILLE ET AL., "Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease", EPIGENETICS : OFFICIAL JOURNAL OF THE DNA METHYLATION SOCIETY, (2012), vol. 7, no. 12, pages 1341 - 1348
    - GIRARDOT, M.; J. CAVAILLE ET AL., "Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease", EPIGENETICS : OFFICIAL JOURNAL OF THE DNA METHYLATION SOCIETY, (2012), vol. 7, no. 12, pages 1341 - 1348
    - LOUWEN, F.; C. MUSCHOL-STEINMETZ ET AL., "A lesson for cancer research: placental microarray gene analysis in preeclampsia", ONCOTARGET, (2012), vol. 3, no. 8, pages 759 - 773
    - DORIDOT, L.; F. MIRALLES ET AL., "Trophoblasts, invasion, and microRNA", FRONTIERS IN GENETICS, (2013), vol. 4, page 248
    - PINELES, B. L.; R. ROMERO ET AL., "Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, (2007), vol. 196, no. 3, doi:doi:10.1016/j.ajog.2007.01.008, pages 261 - 266, XP005913406

DOI:   http://dx.doi.org/10.1016/j.ajog.2007.01.008
    - MAYOR-LYNN, K.; T. TOLOUBEYDOKHTI ET AL., "Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm Labor", REPRODUCTIVE SCIENCES, (2011), vol. 18, no. 1, doi:doi:10.1177/1933719110374115, pages 46 - 56, XP008171764

DOI:   http://dx.doi.org/10.1177/1933719110374115
    - ENQUOBAHRIE, D. A.; D. F. ABETEW ET AL., "Placental microRNA expression in pregnancies complicated by preeclampsia", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, (2011), vol. 204, no. 2, pages 178 E112 - 121
    - ZHU, X. M.; T. HAN ET AL., "Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, (2009), vol. 200, no. 6, doi:doi:10.1016/j.ajog.2008.12.045, pages 661 E661 - 667, XP026142518

DOI:   http://dx.doi.org/10.1016/j.ajog.2008.12.045
    - ISHIBASHI, O.; A. OHKUCHI ET AL., "Hydroxysteroid (17-beta) dehydrogenase 1 is dysregulated by miR-21 0 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia", HYPERTENSION, (2012), vol. 59, no. 2, doi:doi:10.1161/HYPERTENSIONAHA.111.180232, pages 265 - 273, XP055188493

DOI:   http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.180232
    - JI, L.; J. BRKIC ET AL., "Placental trophoblast cell differentiation: Physiological regulation and pathological relevance to preeclampsia", MOLECULAR ASPECTS OF MEDICINE, (2013), vol. 34, no. 5, pages 981 - 1023
    - HUPPERTZ ET AL., HYPERTENSION, (200804), vol. 51, no. 4, pages 970 - 5
    - CHOMCZYNSKI, P.; SACCHI, N., "Single Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction", ANALYTICAL BIOCHEMISTRY, (1987), vol. 162, doi:doi:10.1016/0003-2697(87)90021-2, page 156, XP025650376

DOI:   http://dx.doi.org/10.1016/0003-2697(87)90021-2
    - EMMERTH ET AL., DEV CELL, (20100119), vol. 18, no. 1, pages 102 - 13
 US20040575743
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.